Robert Baffi
CIK: 0001274826
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
Director
Discretionary Trading P&L
Holdings
About BAFFI ROBERT
BAFFI ROBERT (SEC CIK 0001274826) files insider reports with the SEC as Director of Neurogene Inc. (NGNE).
Signal8 holds 2 ownership filings by BAFFI ROBERT, all Form 4s, filed between Jun 13, 2025 and Feb 24, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BAFFI ROBERT's filings is in NEW YORK, NY.
Recent filings by BAFFI ROBERT
Other insiders filing for Neurogene Inc. (NGNE)
- McMinn Rachel, Chief Executive Officer
- Cvijic Christine Mikail, President and CFO
- Woods Keith, Director
- Shafer Christina, Chief Commercial Officer
- Jordan Julie, Chief Medical Officer
- Cobb Stuart, Chief Scientific Officer